Nevertheless, studies thus far have indicated modest sensitivity for KRAS mutation detection in early stage localised PDAC,26 27 33 34 and need for large plasma volumes to detect rare tumour DNA fragments. The gene discussed is KRAS; the disease is neoplasm.